Leader in innovative soft-tissue tissue reconstruction solutions sponsors event advocating for and mentoring women in surgeryMALVERN, Pa., May 09, 2023 TELA Bio, Inc. , a commercial-stage. | May 9, 2023
TELA Bio Highlights Published Clinical Research from 2022 Showcasing Safety and Performance of Reinforced Biologic for Hernia Indications streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
TELA Bio Names Marissa Conrad as Vice President of Clinical and Regulatory Affairs
May 25, 2021 07:00 ET | Source: TELA Bio, Inc. TELA Bio, Inc. Malvern, Pennsylvania, UNITED STATES
MALVERN, Pa., May 25, 2021 (GLOBE NEWSWIRE) TELA Bio, Inc. ( TELA ), a commercial-stage medical technology company focused on designing, developing, and marketing innovative tissue reinforcement materials to address unmet needs in soft tissue reconstruction, announced the appointment of Marissa Conrad as the company s Vice President of Clinical and Regulatory Affairs effective May 24, 2021. As Vice President of Clinical and Regulatory Affairs, Marissa will establish and execute the clinical and regulatory strategy for TELA Bio s current products and future product pipeline.
lbradstream@timesrepublican.com
CONTRIBUTED PHOTO
A nurse draws full a syringe with the Johnson & Johnson vaccine. The demand for the vaccine in Marshall County has increased since eligibility opened, but the supply remains steady at 500 doses per week.
According to information from the Iowa Department of Public Health COVID-19 website, 8,732 Marshall County residents have received COVID-19 vaccinations.
Last week before vaccine eligibility was opened to everyone age 16 and older on Monday 7,356 residents had been dosed.
Marshall County Public Health Nurse Pat Thompson said even though the eligibility has opened considerably, the vaccine shipments remain at 500 per week. Fortunately, she said people are understanding about supply not meeting demand.